Skip to content

Rahul Dhanda

Chief Executive Officer at Syntis BIO.

Earliest Form D on file: Jan 2025

Syntis BIO

Biotech, Boston MA

Chief Executive Officer · signer

  • Signed
  • Named
  • Size is amount sold

Filings

2
  • Jul 2, 2025

    Equity, signed · Form D

    $25M

    of $26.5M

  • Jan 27, 2025

    Equity, option to acquire, security to be acquired, other, signed · Form D

    $6.3M

    of $9M

Network

At Syntis BIO

6 people